Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-02-26
DOI
10.3389/fonc.2019.00108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database
- (2018) Kirsten L. Moek et al. AMERICAN JOURNAL OF PATHOLOGY
- Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma
- (2018) Mikiko Nakamura et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cancer immunotherapy-targeted glypican-3 or neoantigens
- (2018) Yasuhiro Shimizu et al. CANCER SCIENCE
- Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma
- (2018) Jian Zhang et al. MEDICINE
- Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab
- (2018) Gong Chen et al. Oncotarget
- Mutation update for the GPC3 gene involved in Simpson-Golabi-Behmel syndrome and review of the literature
- (2018) Marie-Laure Vuillaume et al. HUMAN MUTATION
- Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity
- (2017) Wenpeng Li et al. HUMAN GENE THERAPY
- Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma
- (2017) Nan Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
- (2017) Takahiro Ishiguro et al. Science Translational Medicine
- Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors
- (2017) Nobuhiro Tsuchiya et al. OncoImmunology
- Glypican 3 as a Serum Marker for Hepatoblastoma
- (2017) Shengmei Zhou et al. Scientific Reports
- A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma
- (2017) Sarah E. Woodfield et al. Scientific Reports
- The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas
- (2016) Giuliana Cassinelli et al. CANCER LETTERS
- Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups
- (2016) Pavel Sumazin et al. HEPATOLOGY
- Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
- (2016) Ghassan K. Abou-Alfa et al. JOURNAL OF HEPATOLOGY
- Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions
- (2016) Henning Reis et al. PATHOLOGY & ONCOLOGY RESEARCH
- Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
- (2016) Chunguang Wang et al. Oncotarget
- Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma
- (2016) Shiro Suzuki et al. OncoImmunology
- Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
- (2016) Yu Sawada et al. OncoImmunology
- Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution
- (2015) Shengmei Zhou et al. HISTOPATHOLOGY
- Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
- (2015) Renato V. Iozzo et al. MATRIX BIOLOGY
- Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis
- (2015) Wei Gao et al. Nature Communications
- Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells
- (2015) Wei Gao et al. PLoS One
- Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma
- (2014) Masafumi Ikeda et al. CANCER SCIENCE
- Glypican 3 Expression in Pediatric Malignant Solid Tumors
- (2014) Sakura Tanaka et al. EUROPEAN JOURNAL OF PEDIATRIC SURGERY
- WNT/β-catenin signaling and hepatocellular carcinoma
- (2014) Jack R. Wands et al. HEPATOLOGY
- Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy
- (2014) Wei Gao et al. HEPATOLOGY
- Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling
- (2014) M. Capurro et al. JOURNAL OF CELL SCIENCE
- Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth
- (2014) Erik H. Knelson et al. JOURNAL OF CLINICAL INVESTIGATION
- Simpson-Golabi-Behmel syndrome types I and II
- (2014) Jair Tenorio et al. Orphanet Journal of Rare Diseases
- Glypican 3 overexpression in primary and metastatic Wilms tumors
- (2014) Maria Tretiakova et al. VIRCHOWS ARCHIV
- First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- Immunohistochemical Expression of Glypican-3 in Pediatric Tumors: An Analysis of 414 Cases
- (2013) Elaine S. Chan et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
- (2013) M. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression
- (2012) Kenichi Kohashi et al. HUMAN PATHOLOGY
- Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP
- (2012) Hui-Lai Miao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
- (2012) Yen Phung et al. mAbs
- Malignant Rhabdoid Tumors Express Stem Cell Factors, Which Relate To the Expression of EZH2 and Id Proteins
- (2011) Sriram Venneti et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
- (2011) E. Doubrovina et al. BLOOD
- Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling
- (2011) Fuchuan Li et al. JOURNAL OF CELL BIOLOGY
- Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas
- (2011) K. Thway et al. JOURNAL OF CLINICAL PATHOLOGY
- Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
- (2010) J. N. Barker et al. BLOOD
- Glypican-3: A new target for cancer immunotherapy
- (2010) Mitchell Ho et al. EUROPEAN JOURNAL OF CANCER
- Wnt/β-catenin signaling in hepatic organogenesis
- (2010) Kari Nejak-Bowen et al. Organogenesis
- Wnt signaling in kidney development and disease
- (2010) Kaisa Pulkkinen et al. Organogenesis
- The Wnt/β-catenin signaling pathway in liver biology and disease
- (2010) Jaideep Behari Expert Review of Gastroenterology & Hepatology
- Expression of Glypican 3 in Ovarian and Extragonadal Germ Cell Tumors
- (2008) Debra L. Zynger et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Oncofetal Protein Glypican-3 Distinguishes Yolk Sac Tumor From Clear Cell Carcinoma of the Ovary
- (2008) Ghada E. Esheba et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
- Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway
- (2008) Wei Cheng et al. CARCINOGENESIS
- Glypican-3 Inhibits Hedgehog Signaling during Development by Competing with Patched for Hedgehog Binding
- (2008) Mariana I. Capurro et al. DEVELOPMENTAL CELL
- Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases
- (2007) Debra L. Zynger et al. HUMAN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started